Leading Research into Head & Neck Cancer

Robotic surgery to increase detection rate

Full project name: Evaluation of the role of tongue base MucOsectomy and Step sErial Sectioning in the diagnostic paradigm for unknown squamous cancers (MOSES)

Tag: Diagnosis

<strong>Tag: </strong>Diagnosis
The problem

Over the past 30 years there has been an alarming increase in the incidence of oropharyngeal cancer, with a large majority of cases related to human papilloma virus (HPV). Some of these patients will present with a cancer from an unknown primary site (CUP).

Work undertaken prior to this study with a patient focus group emphasised the anxiety involved when the primary cancer is not found and the impact of this unknown on mental health. What’s more, for patients with CUP, radiotherapy or chemoradiation requires irradiation of the whole pharynx leading to severe immediate and long-term side effects.

The research
The future
Prof Vinidh Paleri
Prof Vinidh Paleri
Dr John Hardman
Dr John Hardman

Project type:
Project

Project Leader:
Professor Vinidh Paleri

Researcher:
Dr John Hardman

Commencement date:
December 2018

Length of project:
2 years

Funding provided:
£117,991

Funder:
Sir Adrian Swire

Location:
Multi-centre research project at Oxford and Newcastle upon Tyne University Hospitals and The Royal Marsden

Help fund this project

For more information on funding this project specifically please email us

Donate now and together we can save more lives by beating cancer sooner.

Follow us

Get in touch

Call 020 3875 8991

Email info@oraclecancertrust.org

Registered-logos-grey

Oracle Cancer Trust is a registered charity in England and Wales (1142037). A company limited by guarantee. Registered company in England and Wales (7125497). Registered address: 10 Parsons Green House, 27 Parsons Green Lane, London SW6 4HH.